These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 3135179)
1. Continuous subcutaneous infusion of human menopausal gonadotropin in anovulatory women with decreased FSH/LH ratio and androgen excess. Kuroda G; Yano K; Suginami H Endocrinol Jpn; 1988 Feb; 35(1):27-37. PubMed ID: 3135179 [TBL] [Abstract][Full Text] [Related]
2. [Ovulation induction with pulsatile gonadotropin-releasing hormone and continuous human menopausal gonadotropin in polycystic ovarian disease]. Kuroda G Nihon Naibunpi Gakkai Zasshi; 1987 Mar; 63(3):247-59. PubMed ID: 3111899 [TBL] [Abstract][Full Text] [Related]
3. The effect of leuprolide acetate on ovulation induction with human menopausal gonadotropins in polycystic ovary syndrome. Dodson WC; Hughes CL; Whitesides DB; Haney AF J Clin Endocrinol Metab; 1987 Jul; 65(1):95-100. PubMed ID: 2953752 [TBL] [Abstract][Full Text] [Related]
4. Induction of ovulation in polycystic ovary: human menopausal gonadotropin or human urinary follicle stimulating hormone? Venturoli S; Paradisi R; Fabbri R; Porcu E; Orsini LF; Flamigni C Int J Fertil; 1987; 32(1):66-70. PubMed ID: 2880819 [TBL] [Abstract][Full Text] [Related]
5. Androgen response in polycystic ovarian syndrome to FSH treatment after LHRH agonist suppression. Hamori M; Zwirner M; Clédon P; Tinneberg HR Int J Fertil; 1992; 37(3):171-5. PubMed ID: 1355764 [TBL] [Abstract][Full Text] [Related]
6. Ovulation induction in clomiphene-resistant anovulatory women: differential follicular response to purified urinary follicle-stimulating hormone (FSH) versus purified urinary FSH and luteinizing hormone. Hoffman DI; Lobo RA; Campeau JD; Tsai HM; Holmberg EA; Ono T; Frederick JJ; Platt LD; diZerega GS J Clin Endocrinol Metab; 1985 May; 60(5):922-7. PubMed ID: 3920235 [TBL] [Abstract][Full Text] [Related]
8. A comparative, randomized study of low-dose human menopausal gonadotropin and follicle-stimulating hormone in women with polycystic ovarian syndrome. Sagle MA; Hamilton-Fairley D; Kiddy DS; Franks S Fertil Steril; 1991 Jan; 55(1):56-60. PubMed ID: 1898891 [TBL] [Abstract][Full Text] [Related]
9. Ovulation induction with human menopausal gonadotropin versus follicle-stimulating hormone after pituitary suppression by gonadotropin releasing hormone agonist in polycystic ovary disease. A cross-over study. Fulghesu AM; Lanzone A; Guida C; Nicoletti MC; Rossi P; Le Donne M; Caruso A; Mancuso S J Reprod Med; 1992 Oct; 37(10):834-40. PubMed ID: 1479563 [TBL] [Abstract][Full Text] [Related]
10. The use of gonadotropins for the induction of ovulation in women with polycystic ovarian disease. Raj SG; Berger MJ; Grimes EM; Taymor ML Fertil Steril; 1977 Dec; 28(12):1280-4. PubMed ID: 590534 [TBL] [Abstract][Full Text] [Related]
11. Comparison of urinary human follicle-stimulating hormone and human menopausal gonadotropin for ovarian stimulation in polycystic ovarian syndrome. Larsen T; Larsen JF; Schiøler V; Bostofte E; Felding C Fertil Steril; 1990 Mar; 53(3):426-31. PubMed ID: 2106449 [TBL] [Abstract][Full Text] [Related]
13. The effects of the somatostatin analogue octreotide on ovulatory performance in women with polycystic ovaries. Prelevic GM; Ginsburg J; Maletic D; Hardiman P; Okolo S; Balint-Peric L; Thomas M; Orskov H Hum Reprod; 1995 Jan; 10(1):28-32. PubMed ID: 7745065 [TBL] [Abstract][Full Text] [Related]
14. Pharmaco-dynamics of human menopausal gonadotrophin (HMG) and follicle-stimulating hormone (FSH). The importance of the FSH concentration in initiating follicular growth in polycystic ovary-like disease. van Weissenbruch MM; Schoemaker HC; Drexhage HA; Schoemaker J Hum Reprod; 1993 Jun; 8(6):813-21. PubMed ID: 8345068 [TBL] [Abstract][Full Text] [Related]
15. Initial experiences with subcutaneous pulsatile human menopausal gonadotropin administration: successful induction of ovulation in patients with polycystic ovarian disease. Rossmanith WG; Sterzik K; Wolf AS Int J Fertil; 1987; 32(6):460-6. PubMed ID: 2891635 [TBL] [Abstract][Full Text] [Related]
16. Observations on the combination of clomiphene citrate-human menopausal gonadotropin-human chorionic gonadotropin in the management of anovulation. Jarrell J; McInnes R; Cooke R; Arronet G Fertil Steril; 1981 Jun; 35(6):634-7. PubMed ID: 6788606 [TBL] [Abstract][Full Text] [Related]
17. [Ovarian response and induction of ovulation with human menopausal gonadotropin of different ratio of FSH to LH content in women with ovarian insufficiency]. Koyama T; Kamata S; Kubota T; Ohara M; Ichimura M; Saito M Nihon Sanka Fujinka Gakkai Zasshi; 1988 Apr; 40(4):445-51. PubMed ID: 3131463 [TBL] [Abstract][Full Text] [Related]
18. Ovulatory disorders in women with polycystic ovary syndrome. Franks S; Adams J; Mason H; Polson D Clin Obstet Gynaecol; 1985 Sep; 12(3):605-32. PubMed ID: 3933879 [TBL] [Abstract][Full Text] [Related]
19. Bromocriptine treatment in anovulation with decreased ratio of follicle stimulating hormone to luteinizing hormone and with hyperandrogenism. Suginami H; Kuroda G; Yano K; Kitagawa H; Matsuura S Endocrinol Jpn; 1988 Feb; 35(1):47-55. PubMed ID: 2969329 [TBL] [Abstract][Full Text] [Related]
20. Predictive Value of Elevated LH/FSH Ratio for Ovulation Induction in Patients with Polycystic Ovary Syndrome. Woo I; Tobler K; Khafagy A; Christianson MS; Yates M; Garcia J J Reprod Med; 2015; 60(11-12):495-500. PubMed ID: 26775457 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]